Toll Brothers & Travelers Downgraded; Bullish Call for Eli Lily

Eli Lily (LLY) is upgraded but bearish calls for Toll Brothers (TOL) and Travelers (TRV) in Thursday's Analysts' Actions. Toll Brothers was downgraded at RBC Capital to UNDERPERFORM from SECTOR PERFORM. The price target was dropped to $30 from $36. RBC said the luxury homebuilder lacks pricing power and will likely grow slower than its peers. Travelers was downgraded at UBS to NEUTRAL from BUY. The firm made this valuation call saying the insurer's current business fundamentals look fully valued and raised its price target to $105 from $101. The stock is already trading at $105 a share. An upgrade for Eli Lilly at Morgan Stanley to OVERWEIGHT from UNDERWEIGHT. The price target got a boost to $85 from $60, the stock is right now trading at about $74 a share. The firm said it believes the prospects for the drugmaker's pipeline are undervalued.